Search
Edwards Lifesciences Corp
EWAdd to Watchlist
87.360USD
+0.680+0.78%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
50.41BMarket Cap
46.39P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
By BusinessUSD
Name
Revenue
Proportion
Transcatheter Aortic Valve Replacement
4.49B
73.96%
Surgical Heart Valve Therapy
1.03B
16.96%
Transcatheter Mitral and Tricuspid Therapies
550.60M
9.07%
By RegionUSD
Name
Revenue
Proportion
United States
3.54B
58.39%
Europe
1.52B
25.01%
Rest of the world
652.30M
10.75%
Japan
354.70M
5.85%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Transcatheter Aortic Valve Replacement
4.49B
73.96%
Surgical Heart Valve Therapy
1.03B
16.96%
Transcatheter Mitral and Tricuspid Therapies
550.60M
9.07%
